Biocon Ltd

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Karnataka, India
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
BIOCON LIMITED, By: /s/ Kiran Mazumdar-Shaw, Title: Executive Chairperson
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Biocon Ltd

Form 4 holding 10%+ Owner

Bicara Therapeutics Inc.

Security class
Common Stock
Shares / value
4,443,122
Estimated value
$58,842,042
Report date
16 Sep 2024
Price
$13.24
Ownership
By Biocon Limited
Form 4 holding 10%+ Owner

Bicara Therapeutics Inc.

Security class
Common Stock
Shares / value
1,080,775
Estimated value
$14,313,136
Report date
16 Sep 2024
Price
$13.24
Ownership
By Biocon Pharma Inc.
Form 4 holding 10%+ Owner

Bicara Therapeutics Inc.

Security class
Series Seed Redeemable Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
16 Sep 2024
Price
Ownership
By Biocon Limited
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Bicara Therapeutics Inc.

Security class
Series Seed Redeemable Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
16 Sep 2024
Price
Ownership
By Biocon Pharma Inc.
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Biocon Ltd

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .